Myeloma and Related Diseases Registry (MRDR)

Thanks to MRDR participants and contributing sites who provided data for the latest MRDR publication! - 'The Myeloma Landscape in Australia and New Zealand (ANZ): The First Eight Years of the Myeloma and Related Diseases Registry (MRDR)'. The following link takes you to the paper: https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(21)00034-3/fulltext

Find out more

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.

What is the registry?

Learn about how the registry works and the data we collect.
Benefits

Participation in the registry provides advantages for sites and patients.
About our projects

Find out about MRDR projects and how registry data is being used.
4508

Patients accrued

2998

Patients with multiple myeloma

53

Number of approved sites

508

Biobank participants

Latest news

Latest MRDR publication!!
29 Jan 2021

New MRDR publication - check it out!!

Read more
10’s all round for FRAIL-M trial!
22 Dec 2020

MRDR-based FRAIL-M trial now has 10 sites & 10 patients recruited!

Read more
APAC MRDR funding for $5.3 million approved
16 Nov 2020

$5.3 million funding over 5 years approved for APAC MRDR

Read more
4000 participants!!!
02 Oct 2020

The MRDR has reached 4000 patients registered!

Read more

Participating organisations